104540 — CORENTEC CO Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for CORENTEC CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	40,496	44,630	63,909	92,046	93,667
Cost of Revenue
Gross Profit	24,628	27,179	39,951	51,698	49,877
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	37,457	41,840	56,411	85,699	90,895
Operating Profit	3,039	2,790	7,498	6,347	2,772
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,057	2,056	2,465	6,787	163
Provision for Income Taxes
Net Income After Taxes	1,574	764	2,651	5,135	-1,324
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,574	764	1,781	4,055	-2,585
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,574	764	1,781	4,055	-2,585
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	198	118	57.7	280	-163
Dividends per Share